Clinical usefulness of erector spinae plane block for lumbar single level spine surgery

Phase 1

Completed

• Conditions: Other specified spondylopathies,

• Registration Number: CTRI/2019/05/018870
• Lead Sponsor: Hospital administration

Brief Summary

Patients undergoing spine surgeries will have severeperioperative pain which leads to morbidity and demands adequate analgesia. Multimodal analgesia involving NSAIDS, intravenousparacetamol and steroids remains the mainstay for treating the pain in thesepatients. In spite of the adequate usage of the above drugs most of the patientmight require opioids in the immediate postoperative period due to severity ofpain. Regional anaesthesia in these cases is administered by giving the localanaesthetic in the epidural space or giving opioids epidurally orintrathecally, though they are rarely practised.  Erector spinae plane (ESP)block described in 2016 as a novel regional anesthetic technique for acute andchronic thoracic pain by Forerro et al [1]. It has also been usedfor postoperative analgesia for breast surgery [2] and abdominalsurgery [3]. With the advances in usage of ultrasound for regionalanaesthesia, the performance of plane blocks have become much easier and morereliable. The erector spinae plane block is a myofascial plane block where thelocal anaesthetics are deposited in the plane between the erector spinae muscleand the transverse process of the vertebrae. The local anaesthetic therebyblocks the dorsal rami of the spinal nerves mainly and also ventral rami. Weare studying the efficacy of ultrasound guided ESP block for perioperative analgesia onpatients undergoing single level lumbar spine fusion surgery with control group.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-01-05
• Study Completion: 2019-05-31
• Last Update Posted: 2021-03-14

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

•Patients requiring single level fusion surgery at lumbar spine (L1 to L5) for degenerative and lytic changes •ASA I and II patients.

Exclusion Criteria

• Patient refusal 2.
• bleeding disorder 3.
• Local infection.
• Patient who were on chronic drug therapy.
• Adjacent segment disease requiring surgeries 6.
• Inflammatory or infective etiology 7.
• Foreign nationals.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Requirement of opioid analgesia in the perioperative period	At end of 48 hours from start of surgery

Secondary Outcome Measures

Name	Time	Method
Duration of analgesia	Till when rescue analgesia is given

Trial Locations

Locations (2)

Fifth floor orthopedic main operation theatre; 🇮🇳 Coimbatore, TAMIL NADU, India

Orthopedic Operation theatre; 🇮🇳 Coimbatore, TAMIL NADU, India

Fifth floor orthopedic main operation theatre

🇮🇳Coimbatore, TAMIL NADU, India

Dr Madhanmohan C

Principal investigator

09166774973

maddymbbs07@gmail.com